JPMorgan analyst Harlan Sur raised the firm’s price target on Astera Labs (ALAB) to $215 from $180 and keeps an Overweight rating on the shares. The company reported strong results and guidance due to artificial intelligence demand and the ramp of new product cycles, the analyst tells investors in a research note. It sees Astera’s “robust” pipeline supporting continued growth.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Astera Labs, Inc.: Strong Growth and Promising Prospects Drive Buy Rating
- Astera Labs Reports Strong Q3 2025 Financial Performance
- Hold Rating on Sean O’Loughlin: Balancing Strong Performance with Growth Investment and Competitive Uncertainties
- Astera Labs price target raised to $225 from $200 at Roth Capital
- Closing Bell Movers: AMD falls 4% on earnings, Trex, Pinterest down sharply